These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 15768032

  • 1. Beta-catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activation.
    Daniels DL, Weis WI.
    Nat Struct Mol Biol; 2005 Apr; 12(4):364-71. PubMed ID: 15768032
    [Abstract] [Full Text] [Related]

  • 2. Beta-catenin can act as a nuclear import receptor for its partner transcription factor, lymphocyte enhancer factor-1 (lef-1).
    Asally M, Yoneda Y.
    Exp Cell Res; 2005 Aug 15; 308(2):357-63. PubMed ID: 15936755
    [Abstract] [Full Text] [Related]

  • 3. Tcf binding sequence and position determines beta-catenin and Lef-1 responsiveness of MMP-7 promoters.
    Gustavson MD, Crawford HC, Fingleton B, Matrisian LM.
    Mol Carcinog; 2004 Nov 15; 41(3):125-39. PubMed ID: 15457508
    [Abstract] [Full Text] [Related]

  • 4. Dynamic expression of Lef/Tcf family members and beta-catenin during chick gastrulation, neurulation, and early limb development.
    Schmidt M, Patterson M, Farrell E, Münsterberg A.
    Dev Dyn; 2004 Mar 15; 229(3):703-7. PubMed ID: 14991726
    [Abstract] [Full Text] [Related]

  • 5. Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of beta-catenin and TCF/LEF-mediated transcriptional activation.
    Esufali S, Bapat B.
    Oncogene; 2004 Oct 28; 23(50):8260-71. PubMed ID: 15377999
    [Abstract] [Full Text] [Related]

  • 6. Chromatin-specific regulation of LEF-1-beta-catenin transcription activation and inhibition in vitro.
    Tutter AV, Fryer CJ, Jones KA.
    Genes Dev; 2001 Dec 15; 15(24):3342-54. PubMed ID: 11751639
    [Abstract] [Full Text] [Related]

  • 7. Lymphoid enhancer factor 1 makes cells resistant to transforming growth factor beta-induced repression of c-myc.
    Sasaki T, Suzuki H, Yagi K, Furuhashi M, Yao R, Susa S, Noda T, Arai Y, Miyazono K, Kato M.
    Cancer Res; 2003 Feb 15; 63(4):801-6. PubMed ID: 12591729
    [Abstract] [Full Text] [Related]

  • 8. Beta-catenin/Tcf activation partially mimics the transforming activity of Wnt-1 in Rat-1 fibroblasts.
    Young CS, Masckauchan TN, Kitajewski J.
    Differentiation; 2003 Oct 15; 71(8):477-85. PubMed ID: 14641328
    [Abstract] [Full Text] [Related]

  • 9. Hot spots in beta-catenin for interactions with LEF-1, conductin and APC.
    von Kries JP, Winbeck G, Asbrand C, Schwarz-Romond T, Sochnikova N, Dell'Oro A, Behrens J, Birchmeier W.
    Nat Struct Biol; 2000 Sep 15; 7(9):800-7. PubMed ID: 10966653
    [Abstract] [Full Text] [Related]

  • 10. An RNA aptamer that binds to the beta-catenin interaction domain of TCF-1 protein.
    Lee SK, Park MW, Yang EG, Yu J, Jeong S.
    Biochem Biophys Res Commun; 2005 Feb 04; 327(1):294-9. PubMed ID: 15629461
    [Abstract] [Full Text] [Related]

  • 11. Constitutive activation of Wnt/beta-catenin signaling pathway in migration-active melanoma cells: role of LEF-1 in melanoma with increased metastatic potential.
    Murakami T, Toda S, Fujimoto M, Ohtsuki M, Byers HR, Etoh T, Nakagawa H.
    Biochem Biophys Res Commun; 2001 Oct 19; 288(1):8-15. PubMed ID: 11594745
    [Abstract] [Full Text] [Related]

  • 12. Role of a BCL9-related beta-catenin-binding protein, B9L, in tumorigenesis induced by aberrant activation of Wnt signaling.
    Adachi S, Jigami T, Yasui T, Nakano T, Ohwada S, Omori Y, Sugano S, Ohkawara B, Shibuya H, Nakamura T, Akiyama T.
    Cancer Res; 2004 Dec 01; 64(23):8496-501. PubMed ID: 15574752
    [Abstract] [Full Text] [Related]

  • 13. The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors.
    Crawford HC, Fingleton BM, Rudolph-Owen LA, Goss KJ, Rubinfeld B, Polakis P, Matrisian LM.
    Oncogene; 1999 May 06; 18(18):2883-91. PubMed ID: 10362259
    [Abstract] [Full Text] [Related]

  • 14. Activation of Wnt/beta-catenin/Tcf signaling in mouse skin carcinogenesis.
    Bhatia N, Spiegelman VS.
    Mol Carcinog; 2005 Apr 06; 42(4):213-21. PubMed ID: 15765534
    [Abstract] [Full Text] [Related]

  • 15. Identification of MYCBP as a beta-catenin/LEF-1 target using DNA microarray analysis.
    Jung HC, Kim K.
    Life Sci; 2005 Jul 29; 77(11):1249-62. PubMed ID: 15979100
    [Abstract] [Full Text] [Related]

  • 16. Constitutive activation of the Wnt/beta-catenin signalling pathway in acute myeloid leukaemia.
    Simon M, Grandage VL, Linch DC, Khwaja A.
    Oncogene; 2005 Mar 31; 24(14):2410-20. PubMed ID: 15735743
    [Abstract] [Full Text] [Related]

  • 17. A comparative evaluation of beta-catenin and plakoglobin signaling activity.
    Williams BO, Barish GD, Klymkowsky MW, Varmus HE.
    Oncogene; 2000 Nov 23; 19(50):5720-8. PubMed ID: 11126358
    [Abstract] [Full Text] [Related]

  • 18. Plakoglobin (gamma-catenin) has TCF/LEF family-dependent transcriptional activity in beta-catenin-deficient cell line.
    Maeda O, Usami N, Kondo M, Takahashi M, Goto H, Shimokata K, Kusugami K, Sekido Y.
    Oncogene; 2004 Jan 29; 23(4):964-72. PubMed ID: 14661054
    [Abstract] [Full Text] [Related]

  • 19. Role of the intracellular domains of LRP5 and LRP6 in activating the Wnt canonical pathway.
    Mi K, Johnson GV.
    J Cell Biochem; 2005 May 15; 95(2):328-38. PubMed ID: 15778991
    [Abstract] [Full Text] [Related]

  • 20. Wnt signaling is required for thymocyte development and activates Tcf-1 mediated transcription.
    Staal FJ, Meeldijk J, Moerer P, Jay P, van de Weerdt BC, Vainio S, Nolan GP, Clevers H.
    Eur J Immunol; 2001 Jan 15; 31(1):285-93. PubMed ID: 11265645
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.